Rho kinase inhibitors ameliorate cognitive impairment in a male mouse model of methamphetamine-induced schizophrenia
Authors:
Open Access
- 28 June 2023
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 194, 106838
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate moleculesNeurobiology of Disease, 2013
- BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulationFrontiers in Cellular Neuroscience, 2013
- Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalizationJournal of Neurochemistry, 2012
- Haloperidol Regulates the State of Phosphorylation of Ribosomal Protein S6 via Activation of PKA and Phosphorylation of DARPP-32Neuropsychopharmacology, 2011
- Local, persistent activation of Rho GTPases during plasticity of single dendritic spinesNature, 2011
- Rho‐kinase/ROCK: A key regulator of the cytoskeleton and cell polarityCytoskeleton, 2010
- Distinct Roles of Synaptic Transmission in Direct and Indirect Striatal Pathways to Reward and Aversive BehaviorNeuron, 2010
- Extrapyramidal side-effects of antipsychotics in a randomised trialThe British Journal of Psychiatry, 2008
- Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: Implications for abnormalities of glutamate release and NMDA–CaMKII signalingBehavioural Brain Research, 2007
- Enduring vulnerability to reinstatement of methamphetamine‐seeking behavior in glial cell line‐derived neurotrophic factor mutant miceThe FASEB Journal, 2007